359 related articles for article (PubMed ID: 17924986)
21. Technical breakthroughs in the wearable artificial kidney (WAK).
Gura V; Macy AS; Beizai M; Ezon C; Golper TA
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1441-8. PubMed ID: 19696219
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal removal of uremic toxins: can we still do better?
Eloot S; Ledebo I; Ward RA
Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
[TBL] [Abstract][Full Text] [Related]
23. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
Polaschegg HD
Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
[No Abstract] [Full Text] [Related]
24. Effect of cool vs. warm dialysate on toxin removal: rationale and study design.
Maheshwari V; Lau T; Samavedham L; Rangaiah GP
BMC Nephrol; 2015 Feb; 16():25. PubMed ID: 25885180
[TBL] [Abstract][Full Text] [Related]
25. Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate.
Paats J; Adoberg A; Arund J; Fridolin I; Lauri K; Leis L; Luman M; Tanner R
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807387
[TBL] [Abstract][Full Text] [Related]
26. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
[TBL] [Abstract][Full Text] [Related]
27. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
28. Sorbents in treatment of uremia: a short history and a great future.
Ash SR
Semin Dial; 2009; 22(6):615-22. PubMed ID: 20017831
[TBL] [Abstract][Full Text] [Related]
29. Ultrapure dialysate for home hemodialysis?
Ouseph R; Ward RA
Adv Chronic Kidney Dis; 2007 Jul; 14(3):256-62. PubMed ID: 17603979
[TBL] [Abstract][Full Text] [Related]
30. Future Avenues to Decrease Uremic Toxin Concentration.
Vanholder RC; Eloot S; Glorieux GL
Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
[TBL] [Abstract][Full Text] [Related]
31. Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
Maduell F; Vera M; Arias M; Serra N; Blasco M; Bergadá E; Fontsere N; Cases A; Campistol JM
Am J Kidney Dis; 2008 Jul; 52(1):85-92. PubMed ID: 18455852
[TBL] [Abstract][Full Text] [Related]
32. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
Garini G; Savazzi G; Arisi L
Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
[No Abstract] [Full Text] [Related]
33. Basic mechanisms governing solute and fluid transport in hemodialysis.
Misra M
Hemodial Int; 2008 Oct; 12 Suppl 2():S25-8. PubMed ID: 18837766
[TBL] [Abstract][Full Text] [Related]
34. Clamping of the dialysate outlet line in the Genius dialysis system does not alter dialysate flow or clearances.
Van Biesen W; Eloot S; Verleysen A; Glorieux G; Veys N; Vanholder R; Lameire N
Nephrol Dial Transplant; 2006 Apr; 21(4):1069-72. PubMed ID: 16410271
[TBL] [Abstract][Full Text] [Related]
35. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.
Meijers BK; Weber V; Bammens B; Dehaen W; Verbeke K; Falkenhagen D; Evenepoel P
Artif Organs; 2008 Mar; 32(3):214-9. PubMed ID: 18201285
[TBL] [Abstract][Full Text] [Related]
36. [The hemodiafiltration with endogenous reinfusion reduces the erythroid progenitor inhibition by uremic serum].
Aucella F; Scalzulli RP; Vigilante M; Stallone C
G Ital Nefrol; 2004; 21 Suppl 30():S128-32. PubMed ID: 15750970
[TBL] [Abstract][Full Text] [Related]
37. Calculation of the clearance requirements for the development of a hemodialysis-based wearable artificial kidney.
Kim DK; Lee JC; Lee H; Joo KW; Oh KH; Kim YS; Yoon HJ; Kim HC
Hemodial Int; 2016 Apr; 20(2):226-34. PubMed ID: 26245302
[TBL] [Abstract][Full Text] [Related]
38. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
[TBL] [Abstract][Full Text] [Related]
39. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
40. Biofeedback systems and adaptive control hemodialysis treatment.
Azar AT
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):895-903. PubMed ID: 18974573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
